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Introduction: Hearing and vision loss are highly prevalent in elderly adults, and
thus frequently occur in conjunction with cognitive impairments. Studies have shown
that hearing impairment is associated with a higher risk of dementia. However,
evidence concerning the association between vision loss and dementia, as well as the
co-occurrence of vision and hearing loss and dementia, has been inconclusive.
Objectives: To assess the association between: (i) either hearing or vision loss and
the risk of dementia, as well as between; and (ii) the combination of both sensory
impairments and the risk of dementia.
Methods: This case-control study was based on a 5-year data set that included patients
aged 65 years and older who had initially been diagnosed with dementia diseases by
one of 1,203 general practitioners in Germany between January 2013 and December
2017. In total, 61,354 identified dementia cases were matched to non-dementia controls,
resulting in a sample size of 122,708 individuals. Hearing loss and vision loss were
identified using the ICD-10 diagnoses documented in the general practitioners’ files
prior to the initial dementia diagnosis. Multivariate logistic regression models were fitted
to evaluate the associations between visual and/or hearing impairment and the risk of
dementia and controlled for sociodemographic and clinical variables.
Results: Hearing impairment was documented in 11.2% of patients with a dementia
diagnosis and 9.5% of patients without such a diagnosis. Some form of vision
impairment was documented in 28.4% of patients diagnosed with dementia and 28.8%
of controls. Visual impairment was not significantly associated with dementia (OR = 0.97,
CI = 95% 0.97–1.02, p = 0.219). However, patients with hearing impairment were at
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a significantly higher risk of developing dementia (OR = 1.26, CI = 95% 1.15–1.38,
p < 0.001), a finding that very likely led to the observed significant association of the
combination of both visual and hearing impairments and the risk of dementia (OR = 1.14,
CI = 95% 1.04–1.24, p = 0.005).
Discussion: This analysis adds important evidence that contributes to the limited body
of knowledge about the association between hearing and/or vision loss and dementia. It
further demonstrates that, of the two, only hearing impairment affects patients’ cognition
and thus contributes to dementia risk.
Keywords: dementia, hearing impairment, sensory impairments, vision loss, case-control study
BACKGROUND
Aging populations are causing a rapid increase in the number
of people affected by age-associated illnesses, such as dementia
diseases (Prince et al., 2014; Michalowsky et al., 2018).
Worldwide, more than 47million people are currently living with
dementia (PwD), and that number will increase to 75 million
by 2030 (Prince et al., 2013). The worldwide annual cost
of dementia is estimated to be $818 billion (Wimo et al.,
2017). Therefore, dementia diseases currently represent, on
average, one-third of the total societal cost of elderly care,
demonstrating that dementia diseases constitute a healthcare
priority (Michalowsky et al., 2019).
In the absence of a cure, patients need a timely diagnosis
and evidence-based treatment and care in order to control
complications, delay the progression of dementia, and
improve patient-related outcomes [Deutsche Gesellschaft
für Allgemeinmedizin und Familienmedizin e.V.(DEGAM)
(2008); Deutsche Gesellschaft für Psychiatrie, Psychotherapie
und Nervenheilkunde (DGPPN) (2015)]. Furthermore, in
addition to target the delay of disease progression, preventing
or delaying the onset of dementia is key to tackle the existing
healthcare crisis. Several studies have provided substantial
evidence of modifiable risk factors (Kivipelto and Solomon,
2009; Fratiglioni and Qiu, 2011; Mangialasche et al., 2012),
including active engagement in social and physical activities,
as well as mentally stimulating activities, all of which can
determine the risk of late-life dementia. More recently, hearing
and vision loss are evaluated as possible modifiable risk factors
of dementia diseases. Both impairments are very common in
the elderly, and their prevalence increases with age (Wilson
et al., 1999; Agrawal et al., 2008; Bourne et al., 2013; Flaxman
et al., 2017; Homans et al., 2017). Hearing loss is present in
two-thirds of adults aged 70 and older (Lin et al., 2011a,b,c)
and thus very frequently occurs in conjunction with cognitive
impairment. The same applies to vision loss, for which the
leading cause is an uncorrected refractive error or various other
conditions, such as cataracts, age-related macular degeneration,
glaucoma, and diabetic retinopathy (Gohdes et al., 2005;
Albers et al., 2015).
Previous evidence has shown that hearing impairment is
associated with a decrease in cognition and a higher risk
of dementia diseases. The meta-analysis of Wei et al. (2017)
aggregated data on more than 15,000 subjects from different
cohort studies, revealing that hearing loss was associated with
a greater risk for cognitive impairment (RR 1.3, CI 95%
1.12–1.51) and dementia (RR 2.4, CI 95% 1.58–3.61). This
was confirmed in a second meta-analysis recently published
by Loughrey et al. (2018) aggregating different cohort and
cross-sectional studies.
In addition, an uncorrected refractive error, for example,
could also lead to neuropathological changes (Albers et al., 2015).
Therefore, both sensory impairments could be associated with
decreased cognitive function. Based on a retrospective cohort
study, Davies-Kershaw et al. (2018) revealed that moderate
and severe vision loss was significantly associated with an
increased risk of dementia. However, despite this and other
evidence (Reyes-Ortiz et al., 2005; Clemons et al., 2006; Pham
et al., 2006; Rogers and Langa, 2010; Davies-Kershaw et al.,
2018), longitudinal studies have shown inconclusive evidence
concerning the association between vision loss and the risk
of dementia (Lin et al., 2004; Reyes-Ortiz et al., 2005; Sloan
et al., 2005; Valentijn et al., 2005; Fischer et al., 2016; Hong
et al., 2016; Naël et al., 2019). Most studies have focused on
the cognitive decline rather than on dementia, used varied
diagnostic criteria, or have been based on a subjective rather
than an objective assessment, using small sample sizes or
cross-sectional data.
According to the results of recent studies, the combination
of both of these age-related sensory impairments, i.e., vision
and hearing loss, could result in a higher risk of cognitive
decline and dementia diseases. Based on a prospective cohort
study of more than 6,000 women aged 69 and older, Lin et al.
(2004) revealed that vision loss—but not a hearing loss—was
associated with cognitive and functional decline, which is not
in line with the existing evidence for the effect of hearing
impairment. A combination of both sensory impairments was
found to be significantly associated with the greatest odds for
cognitive decline in this study. Contrary to this finding, Hong
et al. (2016) demonstrated, based on a population study of more
than 3,500 participants, that dual sensory impairment was not
significantly associated with a subsequent decline in cognition.
Therefore, the evidence is currently inconclusive, and there
is a scarcity of knowledge regarding the additive combination
of both sensory impairments and their association with a higher
risk of dementia. This study aimed to assess: (i) the association
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between either hearing or vision loss and the risk of dementia
separately, as well as; and (ii) the association of the additive
combination of both sensory impairments—hearing and vision
loss—and the risk of dementia, using a large representative
sample of more than 120,000 German adults aged 65 and older
and an objective measure of sensory impairment.
MATERIALS AND METHODS
Overview
This case-control study was based on a 5-year data set that
included patients aged 65 years and older who had initially been
diagnosed with dementia by one of 1,203 general practitioners
in Germany (cases) between January 2013 and December 2017
(index date) and patients without any dementia diagnoses during
this time period (controls). In total, n = 61,354 identified
dementia cases were matched to non-dementia controls,
resulting in a sample of 122,708 patients with or without
dementia. Hearing loss and vision loss (diagnosed prior to the
dementia diagnosis) were identified using the ICD-10 diagnoses
documented in the general practitioners’ files. Logistic regression
models were conducted to evaluate the association between visual
and/or hearing impairment and dementia.
Database
This study was based on data from the Disease Analyzer database
(IQVIA), which compiles drug prescriptions, diagnoses, and
basic medical and demographic data obtained directly and
in anonymous format from computer systems used in the
practices of general practitioners and specialists (Rathmann
et al., 2018), covering about 3% of all outpatient practices in
Germany. Diagnoses [International Classification of Diseases,
10th revision (ICD-10)], prescriptions [Anatomical Therapeutic
Chemical (ATC) Classification system], and the quality of
reported data are monitored by IQVIA based on a number
of criteria (e.g., completeness of documentation, the linkage
between diagnoses and prescriptions). In Germany, the sampling
methods used to select the practices are appropriate for obtaining
a representative database of primary and specialized care
practices (Rathmann et al., 2018).
Study Population, Sample Size, Participant
Flow, and Drop Out
This case control-study included patients diagnosed with
dementia (ICD-10: F01, F03, G30, F06.7) by one of 1,203 general
practitioners in Germany between January 2013 and December
2017 (Figure 1). Inclusion criteria were as follows: age≥65 years
at the index date; observation time of at least 12 months prior to
the index date.
After applying similar inclusion criteria, dementia cases
were matched to non-dementia controls by age, sex, health
insurance coverage, practice, index year (year of dementia
diagnosis), and comorbidities (diabetes, ischemic heart diseases,
stroke (including transient ischemic attack), intracranial
injury, epilepsy, Parkinson’s disease, and depression). For
the controls, the index date was that of a randomly selected
visit between January 2013 and December 2017 (Figure 1).
Overall, the present study included a total of 122,708 patients,
comprising 61,354 patients with dementia and 61,354 patients
without dementia.
Study Outcomes and Variables
The main outcomes of the study were the associations between
objective hearing and visual impairment and dementia. As
described above, the following ICD-10 diagnoses received on
the index date were used to identify patients with dementia:
F01, F03, G30, and F06.7. In order to identify patients with
hearing impairment prior to the initial dementia diagnosis, as
well as categorize hearing impairment, one of the following
two diagnoses documented by general practitioners was used:
conductive and sensorineural hearing loss (ICD-10 diagnosis:
H90) or other hearing loss (H91). To identify patients with
visual impairment prior to the dementia diagnosis, one or
more of the following diagnoses were used: disorders of
lens (H25–H28), disorders of choroid and retina (H30–H36),
glaucoma (H40–H42), disorders of vitreous body and globe
(H43–H45), disorders of optic nerve and visual pathways
(H46–H48), disorders of ocular muscles, binocular movement,
accommodation and refraction (H49–H52), visual disturbances
(H53), and visual impairment including blindness (H54).
Furthermore, socio-demographic data, including age,
sex, health insurance coverage, and co-existing morbidities
documented prior to the dementia diagnosis, such as diabetes
mellitus (E10–14), ischemic heart disease (I20–I25), stroke
including TIA (I60–I64, G45), intracranial injury (S06), epilepsy
(G40, G41), Parkinson’s disease (G20, G21), and depression
(F32, F33) were assessed.
Statistical Analyses
To validate the matching procedure, differences in the sample
characteristics between those with and those without a
dementia diagnosis were tested by using chi-squared tests
for categorical variables and Wilcoxon tests for continuous
variables. Multivariate logistic regression models were used to
evaluate the association between visual and hearing impairment
and dementia incidence. The association between any or a
specific visual or hearing impairment diagnosis and the risk
of dementia were evaluated separately. That means that, for
each hearing or vision impairment diagnosis, a separate model
was used to test the association between each specific or any
impairment and dementia incidence. In addition, to evaluate
the association between hearing and vision loss and dementia
incidence compared to healthy controls without vision or hearing
impairment, patients were classified into one of the following
four groups: only hearing impairment, only visual impairment,
both hearing, and visual impairment, and no hearing and no
visual impairment (reference group). All models were adjusted
for age, sex, health insurance coverage, and the following
comorbidities: diabetes mellitus, ischemic heart disease, stroke,
intracranial injury, epilepsy, Parkinson’s disease, and depression.
Analyses were carried out using SAS version 9.4.
Ethical Aspects
German law allows for the use of anonymous electronic
medical records for research purposes under certain conditions.
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FIGURE 1 | Study flow chart.
According to German legislation, it is not necessary to obtain
informed consent from patients or approval from a medical
ethics committee for this type of observational study, which
contains no directly identifiable data. Therefore, no protected
health information was available for queries and no Institutional
Review Board (IRB) approval was required for the use of this
database or the completion of this study.
RESULTS
Patients were on average 81 years old, the majority were female
(61%), and more than one-third were suffering from diabetes
(41%), ischemic heart disease (39%), or depression (32%). The
matching procedure successfully resulted in non-significant
differences in socio-demographic and clinical variables between
patients with dementia diseases and non-dementia controls. A
description of the sample is given in Table 1.
Prevalence of Hearing and Vision Loss
Table 2 represents the proportions of patients with and
without dementia and with documented visual and hearing
impairment diagnoses prior to the dementia diagnosis. Hearing
impairment was documented in 11.2% of patients with and
9.5% of patients without dementia. Another hearing loss
(ICD-10 H91) was documented most frequently (10.4% vs.
8.9%), while the conductive and sensorineural hearing loss
was reported less frequently (1.2% vs. 0.9%) in patients
with dementia than in patients without dementia. However,
both were found more often in these patients than in
non-dementia controls.
Vision impairment (of any type) was documented in 28.4%
of patients later diagnosed with dementia compared to 28.8%
of controls. Disorders of the lens (12.6% vs. 12.7%) and visual
disturbances were documented most frequently (9.3% vs. 9.2%).
However, vision loss was nearly equally prevalent in patients with
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TABLE 1 | Basic characteristics of study patients (after 1:1 matching by age,
sex, health insurance coverage, physician, index year, and comorbidities).
Proportion
among
patients with
dementia (%;
n = 61,354)
Proportion
among patients
without
dementia (%;
n = 61,354)
p-value
Age
Mean, SD 80.7 (6.8) 80.7 (6.8) 1.000
Age 65–69 5.5 5.5 1.000
Age 70–79 38.3 38.3
Age 80–89 45.2 45.2
Age ≥90 11.0 11.0
Sex
Female 61.0 61.0 1.000
Male 39.0 39.0
Insurance
Private health insurance 4.9 4.9 1.000
coverage
Statutory health 95.1 95.1
insurance coverage
Comorbidities (documented
diagnoses within
12 months prior to the
index date)
Diabetes mellitus 40.6 40.6 1.000
(E10–14)
Ischemic heart disease 38.5 38.5 1.000
(I20–I25)
Stroke incl. TIA (I60–I64, 15.6 15.6 1.000
G45)
Intracranial injury (S06) 1.5 1.5 1.000
Epilepsy (G40, G41) 2.6 2.6 1.000
Parkinson’s disease 4.4 4.4 1.000
(G20, G21)
Depression (F32, F33) 32.2 32.2 1.000
dementia and those without dementia, without any detectable
trend favoring one of these groups.
The presence of hearing impairment exclusively, without
any vision impairment, was detected in 5.7% of patients with
and 4.5% without dementia. By contrast, vision impairment
exclusively, without any hearing impairment, was found more
often in non-dementia controls (23.9%) compared to patients
later diagnosed with dementia (22.9%). A combination of both
hearing and vision impairment was found in 5.5% of patients
with and 4.9% of patients without dementia.
Association Between Hearing and/or
Vision Loss and Dementia
Any hearing impairment (OR: 1.21, 95% CI 1.13–1.29, p< 0.001)
as well as each separate hearing impairment diagnosis, such as
conductive and sensorineural hearing loss (OR: 1.27, 95% CI
1.05–1.54, p = 0.015) and other hearing loss (OR: 1.20, 95%
CI 1.20–1.28, p < 0.001) were significantly associated with an
increased risk of dementia. No association was observed between
any (OR = 0.98, 95% CI 0.98–1.03, p = 0.434) or a specific visual
impairment diagnosis and dementia.
In addition, the combination of both hearing and visual
impairments was significantly associated with a higher risk of
dementia (OR = 1.14, 95% CI 1.04–1.24, p = 0.005). However,
the risk of developing dementia diseases was lower compared to
the group of patients who had hearing impairment exclusively
(OR = 1.26, 95% CI 1.15–1.38, p < 0.001). Therefore, visual
impairment alone was not significantly associated with dementia
(OR = 0.97, 95% CI 0.97–1.02, p = 0.219) compared to the
reference group of patients without any hearing and visual
impairment. Table 2 shows the results of the multivariate
regression analyses.
DISCUSSION
This analysis adds important evidence that contributes to
the limited body of knowledge on the association between
hearing and/or vision loss and dementia, demonstrating that
hearing impairment only is significantly associated with a
higher risk of dementia. Neither of the documented diagnoses
objectively indicated that vision loss or the combination of
visual and hearing impairment was significantly associated
with dementia.
Several previous studies have evaluated the association
between hearing loss and the risk of dementia. Loughrey et al.
(2018) revealed, based on a meta-analysis of 20,264 subjects from
different prospective cohort studies, that hearing impairment
was significantly associated with dementia diseases (OR 1.28;
CI 95% 1.02–1.59). This finding is in line with the results
of the present analysis. Due to the larger sample size in our
analysis, the confidence interval of our analysis was smaller
and, thus, our results are more precise (Wei et al., 2017;
Loughrey et al., 2018).
However, there is some evidence suggesting that vision loss
is associated with an increased risk of developing dementia
diseases. Based on a retrospective cohort study that included
7,685 patients, Davies-Kershaw et al. (2018) revealed that
patients who rated their own vision as moderate were two
times (HR 2.0, CI 95% 1.4–3.1) and those with very poor
vision, which was comparable to being blind, four times (HR
4.0, CI 95% 2.6–6.1) more likely to have dementia compared
to those without vision impairment. Furthermore, based on a
population cohort of 7,736 initially healthy and non-dementia
patients, Naël et al. (2019) revealed that moderate to severe
near-vision impairment was also associated with an increased
risk of dementia in the first 4 years of follow-up (HR 2.0, CI
95% 1.2–3.3), but not when patients were followed for more
than 4 years. Furthermore, self-reported vision impairment was
associated with an increased risk of dementia within the time
frame of 4 years (HR 1.5, CI 95% 1.1–2.0), but this association
was no longer significant after adjusting for important baseline
covariates, such as cognitive impairment. Therefore, these results
may suggest that vison loss could be associated with an increased
risk in the short-term. However, results remain uncertain in the
long run. Our findings showed that there was no significant
association with an increased risk of dementia for any of the
objective measures of vision loss. Neither refraction disorders
nor severe visual impairment—including blindness—were found
to be significantly associated with an increased risk of dementia
diseases, which is contrary to some previous findings. The study
of Davies-Kershaw et al. (2018) was based on a large nationwide
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TABLE 2 | Prevalence of hearing and vision loss and their association with dementia in general practices in Germany.
Diagnosis (ICD-10 Code) Proportion
among patients
with dementia (%)
Proportion among
patients without
dementia (%)
Odds ratio (95% CI) p-value
Hearing impairment
Any hearing impairment (H90, H91) 11.2 9.5 1.21 (1.13–1.29) <0.001
Conductive and sensorineural hearing loss (H90) 1.2 0.9 1.27 (1.05–1.54) 0.015
Other hearing loss (H91) 10.4 8.9 1.20 (1.12–1.28) <0.001
Visual impairment
Any visual impairment (H25–H54) 28.4 28.8 0.98 (0.94–1.03) 0.434
Disorders of lens (H25–H28) 12.6 12.7 1.00 (0.94–1.06) 0.905
Disorders of choroid and retina (H30–H36) 3.7 3.6 1.03 (0.93–1.14) 0.593
Glaucoma (H40–H42) 4.7 5.0 0.93 (0.85–1.02) 0.110
Disorders of vitreous body and globe (H43–H45) 0.3 0.4 0.83 (0.60–1.14) 0.254
Disorders of optic nerve and visual pathways (H46–H48) 0.2 0.2 0.93 (0.61–1.42) 0.745
Disorders of ocular muscles, binocular movement, accommodation 2.4 2.3 1.02 (0.90–1.16) 0.743
and refraction (H49–H52)
Visual disturbances (H53) 9.3 9.2 1.00 (0.94–1.07) 0.932
Visual impairment including blindness (H54) 5.1 5.4 0.94 (0.86–1.03) 0.174
Having both hearing and visual impairment1 5.5 4.9 1.14 (1.04–1.24) 0.005
Only hearing impairment1 5.7 4.5 1.26 (1.15–1.38) <0.001
Only visual impairment1 22.9 23.9 0.97 (0.93–1.02) 0.219
No hearing and no visual impairment 65.9 66.7 Reference
1Reference: patients without hearing and vision impairment. Multivariate logistic regression models were adjusted for age, sex, health insurance coverage, and the following
comorbidities: diabetes mellitus, ischemic heart disease, stroke, intracranial injury, epilepsy, Parkinson’s disease, and depression.
sample of people aged 50 years and older. However, just 2.5%
(n = 195) of patients in the sample were diagnosed with dementia
diseases, which is well below the general population estimates for
a group of the same age composition. Furthermore, the observed
association was based on a much smaller sample size when
compared to this analysis (Matthews et al., 2013, 2016).
Even though dementia diseases are, in fact, underdiagnosed,
the low number of dementia cases in this study limits
the generalizability of these findings. Furthermore, even
though some studies confirmed the comparability and validity
of subjective and objective measures of vision impairment
(Whillans and Nazroo, 2014), the use of some listed diagnoses
made by general practitioners that are related to vision loss
(Davies-Kershaw et al., 2018) could be a further reason for
the deviating results, especially since only a single question
was used to assess the self-reported vision loss, whatever the
cause of vision loss was. The information given in primary
and secondary data sets could tremendously differ with respect
to the identification of patients’ sensory impairments. Whereas
hearing impairment is usually well-documented in general
practitioners’ files, this does not apply for vision impairment,
as demonstrated by this analysis. Therefore, further research
is needed to evaluate if the secondary datasets are valid for
the identification of sensory impairments, especially vision
impairment. In addition, the ability to self-report vision loss
probably varies according to cognitive capacities. This could be
the reason for the inconsistent findings regarding a significant
association between vision loss and the risk of dementia,
which has been observed in previous studies. Therefore, further
research is needed to clarify the validity of objective and
subjective measures for vision loss, as well as explain the
differences in their association with a higher risk of developing
dementia diseases.
The results of our study demonstrated that only hearing
loss is associated with a higher risk of dementia diseases and
that the combination of both hearing and vision loss certainly
increases sensory impairment, but not the risk of developing
dementia diseases, thus demonstrating the importance of hearing
ability as a protective factor against dementia patients. People
with hearing loss have various neuronal changes. Hearing loss
in older adults may result in an acceleration of aging because
the nervous systems can alter synapses and neural anatomy
(Martini et al., 2014). To compensate for the decreased auditory
input that is caused by hearing loss, more listening effort is
required through the additional recruitment of frontal areas
(Campbell and Sharma, 2013). In hearing-impaired patients,
an increase in cognitive load occurs. Consequently, cognitive
processes such as memory and executive function are adversely
affected (Boyle et al., 2008). Thus, hearing loss may alter the
usual pattern of resource allocation in the brain, affecting neural
reserves and cognitive performance (Lin et al., 2013), and leading
to altered auditory processing. Hence, early onset of hearing
loss in older adults may causally accelerate atrophy in the
entire brain, which could lead to cognitive reserve depletion
in the brain (Lin et al., 2014). The coexistence of hearing loss
in patients living with dementia could cause adverse patient-
related outcomes due to difficulties in participating in daily social
activities and to breakdowns in communication between patients
and caregivers and between patients and professionals. These
challenges, in turn, can lead to social exclusion, increase stress
and fatigue, and exacerbate neuropsychiatric behaviors, such as
apathy, depression, and aggression (Slaughter et al., 2014; Palmer
et al., 2017). All of these are related to a lower health-related
quality of life.
Even though the prevalence of hearing loss in patients
living with dementia is very high and the association between
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hearing loss and cognitive decline is well studied, the utilization
of hearing aids is only moderate (Nirmalasari et al., 2017).
Maharani et al. (2018) revealed that early recognition and
treatment of hearing loss could have the potential to slow down
cognitive decline and potentially delay the onset of dementia,
and should, therefore, be a focus of healthcare providers and
care management models. Therefore, hearing impairment must
be identified early in older adults and in patients living with
dementia, and the unmet need for effective hearing aids must
be met. Collaborative care management approaches could be
a potential tool for improving this situation, and thus help
patients get access to such important aids, which can delay
the progression of this degenerative disease. Therefore, several
commissions—such as, for example, the Lancet Commission
on Dementia Prevention, Intervention, and Care—highlight the
importance of optimizing hearing in patients with dementia
in order to improve the management of psychosis, agitation,
and depression related to this condition (Livingston et al.,
2017). According to the findings of previously published
studies, as well as the current study, early recognition and
treatment of hearing loss has the potential to delay the onset
of dementia diseases and improve patients’ outcomes. It should,
therefore, be a focal point for healthcare providers and care
management models. However, further research is needed to
evaluate the efficacy and cost-effectiveness of such hearing aids
in patients where cognitive impairment or dementia and hearing
loss coexist.
Strengths and Limitations
We conducted a case-control study of patients with and
without a diagnosis of a dementia disease, using data from
GP practices. The diagnoses listed in the files of the general
practitioners are usually used for reimbursement. Therefore, the
data may not be complete, especially not for vision impairment
diagnoses, which are, in most cases, not documented in general
practitioners’ files. Among the elderly, the prevalence of vision
impairment is approximately 70%. In this study, diagnoses
related to vision impairment of any type was only documented
in 28% of cases, demonstrating that vision impairment was
underdiagnosed and underrepresented in this data set. This
limits the generalizability of the non-significant association
found between dementia and vision impairment and should,
therefore, be evaluated in further research, using other objective
or subjective measures.
Furthermore, hearing impairment during the cognitive
assessment or dementia screening procedures might anticipate
the dementia diagnoses due to the fact that patients are
unable to hear and, thus, to understand questions included
in the assessment correctly, even though these patients might
not be cognitively impaired. This could lead to false-positive
dementia diagnoses and, thus, could support the association
between hearing loss and dementia. In addition, our analyses
were based on the initially documented dementia diagnoses. It
should be noted that the basic process for recognizing cognitive
impairment is completely different compared to the process used
for reimbursement purposes. Therefore, the diagnoses used in
the analyses are not verified for their correctness and accuracy.
This also applies to the diagnosis of hearing and vision loss.
In addition, dementia diseases are underdiagnosed by general
practitioners. In Germany, only 40% of PwD are formally
diagnosed with dementia. This diagnosis rate of dementia in
German primary care is well within the range of the international
data (20%–50%; Eichler et al., 2014). This analysis was based on
diagnoses listed in the files of general practitioners. Diagnoses
made by specialists such as neurologists or psychiatrists, who
usually handle the differential diagnosis process, were not
included in this analysis, which limits the generalizability of
the results.
Despite these limitations, the strength of the present study
was that the analysis was based on a total of 122,708 patients
treated by their general practitioners. Therefore, the sample is
adequate for answering the research questions, with considerable
external validity.
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